Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels.

S. Pay,Nurettin Özcan,S. Tokgözoğlu

DOI: https://doi.org/10.1016/S0167-5273(97)00107-1

IF: 4.039

1997-08-08

International Journal of Cardiology

Abstract:

What problem does this paper attempt to address?

Biphasic Reduction of Histone H3 Phosphorylation in Response to N-nitroso Compounds Induced DNA Damage

Kailin Chen,Shuilian Zhang,Xinxin Ke,Hongyan Qi,Jimin Shao,Jing Shen

DOI: https://doi.org/10.1016/j.bbagen.2016.05.028

2016-01-01

Abstract:Background: N-nitroso compounds (NOC) can cause cancers in a wide variety of animal species, and many of them are also potential human carcinogens. However, their underlying genotoxic mechanisms occurred within the context of chromatin, such as aberrant histone modifications, remained elusive.Methods: We investigated the dynamic landscapes of histone modifications after N-nitroso compound N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and N-methyl-N-nitroso-urea (MNU) exposure. Among the altered his tone modifications, we also investigated the control mechanisms of histone H3 phosphorylation changes and its possible implications on transcriptional repression.Results: Significantly, we find a specific biphasic reduction of histone H3 phosphorylation at serine 10 (H3S10ph) and serine 28 (H3S28ph), and a rapid decrease of histone H4 acetylation upon MNNG and MNU exposure. Further investigations reveal that the first hypophosphorylation of H3 occurs in a poly(ADP-ribosyl)ation enzyme PARP-1 (Poly(ADP-Ribose) Polymerase 1) dependent manner, whereas the second decline of H3 phosphorylation is at least partially under the control of histone kinase VRK1 (vaccinia-related kinase 1) and dependent on the tumor suppressor protein p53. In addition, DNA damage induced down-regulation of H3S10/S28 phosphorylation also functions in transcriptional repression of genes, such as cell-cycle regulators.Conclusions: Alkylating damage induced by NOC elicits a biphasic reduction of histone H3 phosphorylation with distinct control mechanisms, which is contributing to DNA damage responses such as the repair-facilitated transcriptional repression.General significance: Identification of the dynamic changes and underlying mechanisms of histone modifications upon NOC exposure would be of great help in understanding the epigenetic regulations of NOC induced DNA damage responses. (C) 2016 Elsevier B.V. All rights reserved.
Isonicotinylation is a Histone Mark Induced by the Anti-Tuberculosis First-Line Drug Isoniazid.

Yuhan Jiang,Yixiao Li,Cheng Liu,Lei Zhang,Danyu Lv,Yejing Weng,Zhongyi Cheng,Xiangmei Chen,Jun Zhan,Hongquan Zhang

DOI: https://doi.org/10.1038/s41467-021-25867-y

IF: 16.6

2021-01-01

Nature Communications

Abstract:Isoniazid (INH) is a first-line anti-tuberculosis drug used for nearly 70 years. However, the mechanism underlying the side effects of INH has remained elusive. Here, we report that INH and its metabolites induce a post-translational modification (PTM) of histones, lysine isonicotinylation (Kinic), also called 4-picolinylation, in cells and mice. INH promotes the biosynthesis of isonicotinyl-CoA (Inic-CoA), a co-factor of intracellular isonicotinylation. Mass spectrometry reveals 26 Kinic sites in histones in HepG2 cells. Acetyltransferases CREB-binding protein (CBP) and P300 catalyse histone Kinic, while histone deacetylase HDAC3 functions as a deisonicotinylase. Notably, MNase sensitivity assay and RNA-seq analysis show that histone Kinic relaxes chromatin structure and promotes gene transcription. INH-mediated histone Kinic upregulates PIK3R1 gene expression and activates the PI3K/Akt/mTOR signalling pathway in liver cancer cells, linking INH to tumourigenicity in the liver. We demonstrate that Kinic is a histone acylation mark with a pyridine ring, which may have broad biological effects. Therefore, INH-induced isonicotinylation potentially accounts for the side effects in patients taking INH long-term for anti-tuberculosis therapy, and this modification may increase the risk of cancer in humans.
SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

Yiran Wang,Xiaolong Zhu,Cong Qiu,Luyang Yu

DOI: https://doi.org/10.1016/j.yjmcc.2019.11.034

2020-01-01

Abstract:The abnormal vascular in tumor promotes tumor cells proliferation and metastasis. Endothelial cell (EC), which is usually dysfunctional in tumor microenvironment, affects angiogenesis and vascular function. Neurogenic locus notch homolog protein 1 (NOTCH1) signaling pathway plays a critical role in vascular endothelial growth factor (VEGF) signaling and angiogenesis by driving its intracellular domain (N1ICD) to nucleus and activates downstream signaling. However, regulatory mechanism of N1ICD remains unclear. Small ubiquitin-like modifier (SUMO) proteins express widely and regulate gene expression, stability, and signal transduction via protein post-translational modification. Our previous study has confirmed that N1ICD could be SUMOylated. In the current study, we first found that SUMOylated N1ICD in ECs negatively regulated angiogenic signaling by enhancing the activity and protein stability of N1ICD. To reveal the role of SUMOylated NICD in tumor angiogenesis, we generated inducible endothelial SUMO1-N1ICD knock-in (SUMO1-N1ICDecKI) mice. Xenograft tumor was produced by subcutaneous injection of mice Lewis Lung Cancer cells on the back and analyzed by volume measurement. SUMO1-N1ICDecKI mice developed smaller tumor than WT mice at 14 days after injection. Immunofluorescence (IF) staining of EC marker also indicated that vessel density of tumors in SUMO1-N1ICDecKI mice was much lower than tumors in WT mice. To further explore the mechanism, VEGFR2 and p-VEGFR2 was measured by IF staining. Increased levels of endothelial-specific N1ICD SUMOylation correlated with lower VEGFR2 expression and p-VEGFR2 signal. On the other hand, we also detected platelet-derived growth factor β (PDGFRβ) to measure vascular integrity. Surprisingly, vessels with enhanced N1ICD SUMOylation associated with more PDFGFβ+ pericyte coverage, indicating that endothelial N1ICD SUMOylation promotes vessel stability. Taken together, we conclude that endothelial-specific N1ICD SUMOylation suppressed tumor growth and tumor angiogenesis while protected vascular integrity.
Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

Shengduo Liu,Pinglong Xu

DOI: https://doi.org/10.3724/zdxbyxb-2023-0480

2024-01-01

Abstract:Innate nucleic acid sensing is a ubiquitous and highly conserved immunological process, which is pivotal for monitoring and responding to pathogenic invasion and cellular damage, and central to host defense, autoimmunity, cell fate determination and tumorigenesis. Tyrosine phosphorylation, a major type of post-translational modification, plays a critical regulatory role in innate immune sensing pathway. Core members of nucleic acid sensing signaling pathway, such as cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS), stimulator of interferon genes (STING), and TANK binding kinase 1 (TBK1), are all subject to activity regulation triggered by tyrosine phosphorylation, thereby affecting the host antiviral defense and anti-tumor immunity under physiological or pathological conditions. This review summarizes the recent advances in research on tyrosine kinases and tyrosine phosphorylation in regulation of nucleic acid sensing. The function and potential applications of targeting tyrosine phosphorylation in anti-tumor immunity is disussed to provide insights for understanding and expanding new anti-tumor strategies.
Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

X Guo,D S Waddell,W Wang,Z Wang,N T Liberati,S Yong,X Liu,X-F Wang

DOI: https://doi.org/10.1038/onc.2008.337

IF: 8.756

2008-01-01

Oncogene

Abstract:Transforming growth factor-beta (TGF-β) elicits a variety of cellular activities primarily through a signaling cascade mediated by two key transcription factors, Smad2 and Smad3. Numerous regulatory mechanisms exist to control the activity of Smad3, thereby modulating the strength and specificity of TGF-β responses. In search for potential regulators of Smad3 through a yeast two-hybrid screen, we identified casein kinase 1 gamma 2 (CKIγ2) as a novel Smad3-interacting protein. In mammalian cells, CKIγ2 selectively and constitutively binds Smad3 but not Smad1, -2 or -4. Functionally, CKIγ2 inhibits Smad3-mediated TGF-β responses including induction of target genes and cell growth arrest, and this inhibition is dependent on CKIγ2 kinase activity. Mechanistically, CKIγ2 does not affect the basal levels of Smad proteins or activity of the receptors. Rather, CKIγ2 preferentially promotes the ubiquitination and degradation of activated Smad3 through direct phosphorylation of its MH2 domain at Ser418. Importantly, mutation of Ser418 to alanine or aspartic acid causes an increase or decrease of Smad3 activity, respectively, in the presence of TGF-β. CKIγ2 is the first kinase known to mark activated Smad3 for destruction. Given its negative function in TGF-β signaling and its reported overexpression in human cancers, CKIγ2 may act as an oncoprotein during tumorigenesis.
Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

X Guo,D S Waddell,W Wang,Z Wang,N T Liberati,S Yong,X Liu,X-F Wang

DOI: https://doi.org/10.1038/onc.2008.337

IF: 8.756

2008-01-01

Oncogene

Abstract:Transforming growth factor-beta (TGF-beta) elicits a variety of cellular activities primarily through a signaling cascade mediated by two key transcription factors, Smad2 and Smad3. Numerous regulatory mechanisms exist to control the activity of Smad3, thereby modulating the strength and specificity of TGF-beta responses. In search for potential regulators of Smad3 through a yeast two-hybrid screen, we identified casein kinase 1 gamma 2 (CKI gamma 2) as a novel Smad3-interacting protein. In mammalian cells, CKI gamma 2 selectively and constitutively binds Smad3 but not Smad1, -2 or -4. Functionally, CKI gamma 2 inhibits Smad3-mediated TGF-beta responses including induction of target genes and cell growth arrest, and this inhibition is dependent on CKI gamma 2 kinase activity. Mechanistically, CKI gamma 2 does not affect the basal levels of Smad proteins or activity of the receptors. Rather, CKI gamma 2 preferentially promotes the ubiquitination and degradation of activated Smad3 through direct phosphorylation of its MH2 domain at Ser418. Importantly, mutation of Ser418 to alanine or aspartic acid causes an increase or decrease of Smad3 activity, respectively, in the presence of TGF-beta. CKI gamma 2 is the first kinase known to mark activated Smad3 for destruction. Given its negative function in TGF-beta signaling and its reported overexpression in human cancers, CKI gamma 2 may act as an oncoprotein during tumorigenesis.
Inhibition of Syk Promotes Chemical Reprogramming of Fibroblasts Via Metabolic Rewiring and H2 S Production.

Weiyun Wang,Shaofang Ren,Yunkun Lu,Xi Chen,Juanjuan Qu,Xiaojie Ma,Qian Deng,Zhensheng Hu,Yan Jin,Ziyu Zhou,Wenyan Ge,Yibing Zhu,Nannan Yang,Qin Li,Jiaqi Pu,Guo Chen,Cunqi Ye,Hao Wang,Xiaoyang Zhao,Zhiqiang Liu,Saiyong Zhu

DOI: https://doi.org/10.15252/embj.2020106771

2021-01-01

Abstract:Chemical compounds have recently been introduced as alternative and non-integrating inducers of pluripotent stem cell fate. However, chemical reprogramming is hampered by low efficiency and the molecular mechanisms remain poorly characterized. Here, we show that inhibition of spleen tyrosine kinase (Syk) by R406 significantly promotes mouse chemical reprogramming. Mechanistically, R406 alleviates Syk / calcineurin (Cn) / nuclear factor of activated T cells (NFAT) signaling-mediated suppression of glycine, serine, and threonine metabolic genes and dependent metabolites. Syk inhibition upregulates glycine level and downstream transsulfuration cysteine biosynthesis, promoting cysteine metabolism and cellular hydrogen sulfide (H2 S) production. This metabolic rewiring decreased oxidative phosphorylation and ROS levels, enhancing chemical reprogramming. In sum, our study identifies Syk-Cn-NFAT signaling axis as a new barrier of chemical reprogramming and suggests metabolic rewiring and redox homeostasis as important opportunities for controlling cell fates.
KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling

Bo Yu,Jun Su,Qiqi Shi,Qing Liu,Jun Ma,Guoqing Ru,Lei Zhang,Jian Zhang,Xichun Hu,Jianming Tang

DOI: https://doi.org/10.1038/s41467-022-29899-w

IF: 16.6

2022-04-21

Nature Communications

Abstract:Abstract Smad nuclear-interacting protein 1 (SNIP1) is a transcription repressor related to the TGF-β signaling pathway and associates with c-MYC, a key regulator of cell proliferation and tumor development. Currently, the mechanism by which SNIP1 regulates tumorigenesis and cancer metastasis is unknown. Here, we identify that SNIP1 is a non-histone substrate of lysine methyltransferase KMT5A, which undergoes KMT5A-mediated mono-methylation to promote breast cancer cell growth, invasion and lung metastasis. Mechanistically, we show KMT5A-mediated K301 methylation of SNIP1 represents a sensing signal to release histone acetyltransferase KAT2A and promotes the interaction of c-MYC and KAT2A, and the recruitment of c-MYC/KAT2A complex to promoter of c-MYC targets. This event ultimately inhibits the Hippo kinase cascade to enhance triple-negative breast cancer (TNBC) metastasis by transcriptionally activating MARK4. Co-inhibition of KMT5A catalytic activity and YAP in TNBC xenograft-bearing animals attenuates breast cancer metastasis and increases survival. Collectively, this study presents an KMT5A methylation-dependent regulatory mechanism governing oncogenic function of SNIP1.

multidisciplinary sciences
SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity

Ji An Kang,Yoon Jung Kim,Kyu Yun Jang,Hye Won Moon,Haeseung Lee,Seonjeong Lee,Hyun Kyu Song,Sang Woo Cho,Yoon Sun Yoo,Hye Gyeong Han,Min-Ju Kim,Myoung Ja Chung,Cheol Yong Choi,Cheolju Lee,Chaeuk Chung,Gang Min Hur,You-Sun Kim,Young Joo Jeon

DOI: https://doi.org/10.1038/s12276-024-01194-2

2024-03-06

Experimental & Molecular Medicine

Abstract:ISG15 is an interferon-stimulated ubiquitin-like protein (UBL) with multifaceted roles as a posttranslational modifier in ISG15 conjugation (ISGylation). However, the mechanistic consequences of ISGylation in cancer have not been fully elucidated, largely due to a lack of knowledge on the ISG15 target repertoire. Here, we identified SIRT1, a nicotinamide adenine dinucleotide (NAD + )-dependent protein deacetylase, as a new target for ISGylation. SIRT1 ISGylation impairs the association of SIRT1 with its negative regulator, deleted in breast cancer 1 (DBC1), which unleashes SIRT1 from its inactive state and leads to an increase in its deacetylase activity. Importantly, SIRT1 ISGylation promoted lung cancer progression and limited lung cancer cell sensitivity to DNA damage-based therapeutics in vivo and in vitro models. The levels of ISG15 mRNA and protein were significantly higher in lung cancer tissues than in adjacent normal tissues. Accordingly, elevated expression of SIRT1 and ISG15 was associated with poor prognosis in lung cancer patients, a finding that could be translated for lung cancer patient stratification and disease outcome evaluation. Taken together, our findings provide a mechanistic understanding of the regulatory effect of SIRT1 ISGylation on tumor progression and therapeutic efficacy in lung cancer.

biochemistry & molecular biology,medicine, research & experimental
Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells

Long He,Jennifer Endress,Sungyun Cho,Zhongchi Li,Yuxiang Zheng,John M Asara,John Blenis,John M. Asara

DOI: https://doi.org/10.1126/sciadv.abm8786

IF: 13.6

2022-05-20

Science Advances

Abstract:Serine/one-carbon metabolism provides critical resources for nucleotide biosynthesis and epigenetic maintenance and is thus necessary in cancer cell growth, although the detailed regulatory mechanisms remain unclear. We uncover a critical role of glycogen synthase kinase 3 (GSK3) in regulating the expression of serine/one-carbon metabolic enzymes. Nuclear enrichment of GSK3 significantly suppresses genes that mediate de novo serine synthesis, including PHGDH, PSAT1, PSPH, and one-carbon metabolism, including SHMT2 and MTHFD2. FRAT1 promotes nuclear exclusion of GSK3, enhances serine/one-carbon metabolism, and, as a result, confers cell vulnerability to inhibitors that target this metabolic process such as SHIN1, a specific SHMT1/2 inhibitor. Furthermore, pharmacological or genetic suppression of GSK3 promotes serine/one-carbon metabolism and exhibits a significant synergistic effect in combination with SHIN1 in suppressing cancer cell proliferation in cultured cells and in vivo. Our observations indicate that inhibition of nuclear GSK3 signaling creates a vulnerability, which results in enhanced efficacy of serine/one-carbon metabolism inhibitors for the treatment of cancer.

multidisciplinary sciences
Sulfopin, a selective covalent inhibitor of Pin1, blocks Myc-driven tumor initiation and growth<i>in vivo</i>

Christian Dubiella,Benika J. Pinch,Daniel Zaidman,Theresa D. Manz,Evon Poon,Shuning He,Efrat Resnick,Ellen M. Langer,Colin J. Daniel,Hyuk-Soo Seo,Ying Chen,Scott B. Ficarro,Yann Jamin,Xiaolan Lian,Shin Kibe,Shingo Kozono,Kazuhiro Koikawa,Zainab M. Doctor,Behnam Nabet,Christopher M. Browne,Annan Yang,Liat Stoler-Barak,Richa B. Shah,Nick E. Vangos,Ezekiel A. Geffken,Roni Oren,Samuel Sidi,Ziv Shulman,Chu Wang,Jarrod A. Marto,Sirano Dhe-Paganon,Thomas Look,Xiao Zhen Zhou,Kun Ping Lu,Rosalie C. Sears,Louis Chesler,Nathanael S. Gray,Nir London

DOI: https://doi.org/10.1101/2020.03.20.998443

2020-01-01

Abstract:AbstractThe peptidyl-prolyl cis-trans isomerase, Pin1, acts as a unified signaling hub that is exploited in cancer to activate oncogenes and inactivate tumor suppressors, in particular through up-regulation of c-Myc target genes. However, despite considerable efforts, Pin1 has remained an elusive drug target. Here, we screened an electrophilic fragment library to discover covalent inhibitors targeting Pin1’s active site nucleophile - Cys113, leading to the development of Sulfopin, a double-digit nanomolar Pin1 inhibitor. Sulfopin is highly selective for Pin1, as validated by two independent chemoproteomics methods, achieves potent cellular andin vivotarget engagement, and phenocopies genetic knockout of Pin1. Although Pin1 inhibition had a modest effect on viability in cancer cell cultures, Sulfopin induced downregulation of c-Myc target genes and reduced tumor initiation and tumor progression in murine and zebrafish models of MYCN-driven neuroblastoma. Our results suggest that Sulfopin is a suitable chemical probe for assessing Pin1-dependent pharmacology in cells andin vivo. Moreover, these studies indicate that Pin1 should be further investigated as a potential cancer target.
PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest

Yangyang Yuan,Chenwei Wang,Xuran Zhuang,Shaofeng Lin,Miaomiao Luo,Wankun Deng,Jiaqi Zhou,Lihui Liu,Lina Mao,Wenbo Peng,Jian Chen,Qiangsong Wang,Yilai Shu,Yu Xue,Pengyu Huang

DOI: https://doi.org/10.1038/s41467-022-32976-9

IF: 16.6

2022-09-06

Nature Communications

Abstract:Abstract Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quantitative transcriptomic and phosphoproteomic data. Using known kinases associated with anti-cancer drug resistance, the accuracy of our method denoted by the area under the curve is 5.2% to 29.5% higher than Kinase-Substrate Enrichment Analysis. We further use this method to analyze trans-omic data in hepatocyte maturation and hepatic reprogramming of human dermal fibroblasts, uncovering 5 kinases as regulators in the two processes. Further experiments reveal that a serine/threonine kinase, PIM1, promotes hepatic conversion and protects human dermal fibroblasts from reprogramming-induced ferroptosis and cell cycle arrest. This study not only reveals new regulatory kinases, but also provides a helpful method that might be extended to predict central kinases involved in other biological processes.

multidisciplinary sciences
The immune regulation and therapeutic potential of the SMAD gene family in breast cancer

Zhuo Chen,Yu Wang,Xiaodi Lu,Hong Chen,Yiran Kong,Liwei Rong,Guonian Wang

DOI: https://doi.org/10.1038/s41598-024-57189-6

IF: 4.6

2024-03-23

Scientific Reports

Abstract:Breast cancer is a serious threat to human health. The transforming growth factor-β signaling pathway is an important pathway involved in the occurrence and development of cancer. The SMAD family genes are responsible for the TGF-β signaling pathway. However, the mechanism by which genes of the SMAD family are involved in breast cancer is still unclear. Therefore, it is necessary to investigate the biological roles of the SMAD family genes in breast cancer. We downloaded the gene expression data, gene mutation data, and clinical pathological data of breast cancer patients from the UCSC Xena database. We used the Wilcox test to estimate the expression of genes of the SMAD family in cancers. And the biological functions of SMAD family genes using the DAVID website. The Pearson correlation method was used to explore the immune cell infiltration and drug response of SMAD family genes. We conducted in biological experiments vitro and vivo. In this study, we integrated the multi-omics data from TCGA breast cancer patients for analysis. The expression of genes of SMAD family was significantly dysregulated in patients with breast cancer. Except for SMAD6, the expression of other SMAD family genes was positively correlated. We also found that genes of the SMAD family were significantly enriched in the TGF-β signaling pathway, Hippo signaling pathway, cell cycle, and cancer-related pathways. In addition, SMAD3, SMAD6, and SMAD7 were lowly expressed in stage II breast cancer, while SMAD4 and SMAD2 were lowly expressed in stage III cancer. Furthermore, the expression of genes of the SMAD family was significantly correlated with immune cell infiltration scores. Constructing a xenograft tumor mouse model, we found that SMAD3 knockdown significantly inhibited tumorigenesis. Finally, we analyzed the association between these genes and the IC50 value of drugs. Interestingly, patients with high expression of SMAD3 exhibited significant resistance to dasatinib and staurosporine, while high sensitivity to tamoxifen and auranofin. In addition, SMAD3 knockdown promoted the apoptosis of BT-549 cells and decreased cell activity, and BAY-1161909 and XK-469 increased drug efficacy. In conclusion, genes of the SMAD family play a crucial role in the development of breast cancer.

multidisciplinary sciences
SNIP 1 Recruits TET 2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response

Lei-Lei Chen,Huai-Peng Lin,Wen-Jie Zhou,Chen-Xi He,Zhi-Yong Zhang,Zhou-Li,Cheng,Jun-Bin Song,Peng Liu,Xin-Yu Chen,Yu-Kun Xia,Xiu-Fei Chen,Ren-Qiang,Sun,Jing-Ye Zhang,Yi-Ping Sun,Lei Song,Bing-Jie Liu,Rui-Kai Du,Chen Ding,Fei,Lan,Sheng-Lin Huang,Feng Zhou,Suling Liu,Yue Xiong,Dan Ye,- Kun,Liang Guan

2019-01-01

Abstract:Lei-Lei Chen#1, Huai-Peng Lin#1,2, Wen-Jie Zhou1, Chen-Xi He1, Zhi-Yong Zhang1, Zhou-Li Cheng1, Jun-Bin Song1, Peng Liu1, Xin-Yu Chen1, Yu-Kun Xia1, Xiu-Fei Chen1, Ren-Qiang Sun1, Jing-Ye Zhang1, Yi-Ping Sun1, Lei Song3, Bing-Jie Liu4, Rui-Kai Du4, Chen Ding3, Fei Lan1, Sheng-Lin Huang1, Feng Zhou1, Suling Liu4, Yue Xiong1,5,*, Dan Ye1,6,*, and KunLiang Guan1,7,9,* 1Huashan Hospital and Key Laboratory of Medical Epigenetics and Metabolism and Molecular and Cell Biology Lab, Institute of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China
Go-Ichi-Ni-San 2: A Potential Biomarker and Therapeutic Target in Human Cancers.

Dan-Dan Shan,Qiu-Xian Zheng,Zhi Chen

DOI: https://doi.org/10.4251/wjgo.v14.i10.1892

2022-01-01

World Journal of Gastrointestinal Oncology

Abstract:Cancer incidence and mortality are increasing globally, leading to its rising status as a leading cause of death. The Go-Ichi-Ni-San (GINS) complex plays a crucial role in DNA replication and the cell cycle. The GINS complex consists of four subunits encoded by the GINS1, GINS2, GINS3, and GINS4 genes. Recent findings have shown that GINS2 expression is upregulated in many diseases, particularly tumors. For example, increased GINS2 expression has been found in cervical cancer, gastric adenocarcinoma, glioma, non-small cell lung cancer, and pancreatic cancer. It correlates with the clinicopathological characteristics of the tumors. In addition, high GINS2 expression plays a pro-carcinogenic role in tumor development by promoting tumor cell proliferation and migration, inhibiting tumor cell apoptosis, and blocking the cell cycle. This review describes the upregulation of GINS2 expression in most human tumors and the pathway of GINS2 in tumor development. GINS2 may serve as a new marker for tumor diagnosis and a new biological target for therapy.
Nicotinic acid suppresses liver cancer metastasis via histone lysine nicotinylation

Hong-Quan Zhang,Yuhan Jiang,Yixiao Li,Lei Zhang,Haoyi Yan,Ziheng Qin,Qianchen Li,Yidi Peng,Jia Liu,Yejing Weng,Zhongyi Cheng,Danyu Lv,Jing Zhang,Yan Tang,Jun Zhan

DOI: https://doi.org/10.21203/rs.3.rs-3973350/v1

2024-01-01

Abstract:Abstract Vitamin B3 is the major precursor of NAD+ and NADP+, however it was unknown whether this vitamin supplementation could modify histone epigenetically. Here, we report nicotinic acid (NA), a component of vitamin B3, suppresses liver cancer metastasis specifically, via stimulating histone lysine nicotinylation (Knic). Importantly, nicotinyl-CoA, that metabolically generated by NA via ACSS2, stimulates histone Knic in vivo and in vitro. Histone Knic regulates chromatin accessibility and inhibits binding of transcription factor HOXB9 to the promoter of oncogene PPFIA1, resulting in inhibition of hepatocyte carcinoma progression. Notably, we found that NA specific induces histone Knic and suppresses hepatocyte carcinoma progression, whereas nicotinamide, an amide form of nicotinic acid, does not stimulate nicotinylation, instead promotes tumour growth and metastasis. These findings suggest that vitamin B3 supplementation may contribute to cancer progression depending on its composition. Collectively, we demonstrated that histone lysine nicotinylation is a histone mark controlling gene expression and NA supresses liver cancer progression by inducing histone lysine nicotinylation.
Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation

Jong Ho Park,Amir H Ameri,Kaitlin E Dempsey,Danielle N Conrad,Marina Kem,Mari Mino‐Kenudson,Shadmehr Demehri

DOI: https://doi.org/10.15252/embj.2020106151

2021-02-22

The EMBO Journal

Abstract:Interleukin (IL)-33 cytokine plays a critical role in allergic diseases and cancer. IL-33 also has a nuclear localization signal. However, the nuclear function of IL-33 and its impact on cancer is unknown. Here, we demonstrate that nuclear IL-33-mediated activation of SMAD signaling pathway in epithelial cells is essential for cancer development in chronic inflammation. Using RNA and ChIP sequencing, we found that nuclear IL-33 repressed the expression of an inhibitory SMAD, Smad6, by interacting with its transcription factor, RUNX2. IL-33 was highly expressed in the skin and pancreatic epithelial cells in chronic inflammation, leading to a markedly repressed Smad6 expression as well as dramatically upregulated p-SMAD2/3 and p-SMAD1/5 in the epithelial cells. Blocking TGF-β/SMAD signaling attenuated the IL-33-induced cell proliferation in vitro and inhibited IL-33-dependent epidermal hyperplasia and skin cancer development in vivo. IL-33 and SMAD signaling were upregulated in human skin cancer, pancreatitis, and pancreatitis-associated pancreatic cancer. Collectively, our findings reveal that nuclear IL-33/SMAD signaling is a cell-autonomous tumor-promoting axis in chronic inflammation, which can be targeted by small-molecule inhibitors for cancer treatment and prevention.
Purification of an atypical bovine interferon induced in response to heat shock in bovine cultured cells. Characterization in comparison with the classical alpha, beta and gamma interferon.

Y. Gachet,G. Carpentier,S. Chousterman

IF: 4.372

Biochimie

Abstract:Heat-shock induced factor (HSIF) was excreted by bovine MDBK cells during their recovery period after a heat shock. This factor has the capacity to induce 2',5' oligoadenylate synthetase activity, an enzyme generally by interferon treatment (J Biol Chem (1987) 262, 4806-4811). We have observed that an antiviral state was also produced in response to heat shock. HSIF was purified 10,000-fold and different techniques showed a copurification of both activities. Certain properties of HSIF were established, such as its molecular mass (45 kDa) and isoelectric point (6.8). This cytokine was acid-sensitive as IFN gamma (type II) and temperature labile contrarily to alpha, beta and gamma bovine IFN. Immunoprecipitation and comparative chromatography on lectines or polynucleotides established that HSIF was structurally different from the three classes of bovine IFN. Moreover, two-dimensional electrophoresis and comparative analysis of [35S] methionine-labeled proteins induced by HSIF alpha, beta or gamma bovine IFN showed that HSIF induces a specific set of proteins. Taken together, all these results strongly suggest that HSIF is a new atypical bovine interferon induced in response to heat shock.
The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels

Abdul Basit,Min-Guk Cho,Eui-Yun Kim,Dohyeong Kwon,Suk-Jo Kang,Jae-Ho Lee

DOI: https://doi.org/10.1038/s12276-020-0416-y

Abstract:Chromosomal instability (CIN) in cancer cells has been reported to activate the cGAS-STING innate immunity pathway via micronuclei formation, thus affecting tumor immunity and tumor progression. However, adverse effects of the cGAS/STING pathway as they relate to CIN have not yet been investigated. We addressed this issue using knockdown and add-back approaches to analyze each component of the cGAS/STING/TBK1/IRF3 pathway, and we monitored the extent of CIN by measuring micronuclei formation after release from nocodazole-induced mitotic arrest. Interestingly, knockdown of cGAS (cyclic GMP-AMP synthase) along with induction of mitotic arrest in HeLa and U2OS cancer cells clearly resulted in increased micronuclei formation and chromosome missegregation. Knockdown of STING (stimulator of interferon genes), TBK1 (TANK-binding kinase-1), or IRF3 (interferon regulatory factor-3) also resulted in increased micronuclei formation. Moreover, transfection with cGAMP, the product of cGAS enzymatic activity, as well as add-back of cGAS WT (but not catalytic-dead mutant cGAS), or WT or constitutively active STING (but not an inactive STING mutant) rescued the micronuclei phenotype, demonstrating that all components of the cGAS/STING/TBK1/IRF3 pathway play a role in preventing CIN. Moreover, p21 levels were decreased in cGAS-, STING-, TBK1-, and IRF3-knockdown cells, which was accompanied by the precocious G2/M transition of cells and the enhanced micronuclei phenotype. Overexpression of p21 or inhibition of CDK1 in cGAS-depleted cells reduced micronuclei formation and abrogated the precocious G2/M transition, indicating that the decrease in p21 and the subsequent precocious G2/M transition is the main mechanism underlying the induction of CIN through disruption of cGAS/STING signaling.

Elevated Lp(a) is the most frequent familial lipoprotein disorder leading to premature myocardial infarction in a country with low cholesterol levels.

Biphasic Reduction of Histone H3 Phosphorylation in Response to N-nitroso Compounds Induced DNA Damage

Isonicotinylation is a Histone Mark Induced by the Anti-Tuberculosis First-Line Drug Isoniazid.

SUMOylated NICD in Endothelial Cell Suppresses Tumor Angiogenesis

Advancements in Tyrosine Kinase-Mediated Regulation of Innate Nucleic Acid Sensing.

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

Inhibition of Syk Promotes Chemical Reprogramming of Fibroblasts Via Metabolic Rewiring and H2 S Production.

KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling

SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activity

Suppression of nuclear GSK3 signaling promotes serine/one-carbon metabolism and confers metabolic vulnerability in lung cancer cells

Sulfopin, a selective covalent inhibitor of Pin1, blocks Myc-driven tumor initiation and growth<i>in vivo</i>

PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest

The immune regulation and therapeutic potential of the SMAD gene family in breast cancer

SNIP 1 Recruits TET 2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response

Go-Ichi-Ni-San 2: A Potential Biomarker and Therapeutic Target in Human Cancers.

Nicotinic acid suppresses liver cancer metastasis via histone lysine nicotinylation

Nuclear IL‐33/SMAD signaling axis promotes cancer development in chronic inflammation

Purification of an atypical bovine interferon induced in response to heat shock in bovine cultured cells. Characterization in comparison with the classical alpha, beta and gamma interferon.

The cGAS/STING/TBK1/IRF3 innate immunity pathway maintains chromosomal stability through regulation of p21 levels